Investor Overview

Webcast Image Webcast
Q2 2019 Stereotaxis Inc. Earnings Conference Call
08/08/19 9:00 am EDT
Q2 2019 Stereotaxis Inc. Earnings Conference Call

08/08/19 9:00 am EDT   
Webcast Presentation  
Corporate Profile
 

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. Stereotaxis' core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive™ robotic navigation system and consumables, which have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere.

FINANCIAL NEWS
08/08/19
ST. LOUIS , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results for the second quarter ended June 30, 2019 . In a separate press release issued concurrently with
08/08/19
ST. LOUIS , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it has entered into a securities purchase agreement with select institutional investors for a $25 million
08/07/19
ST. LOUIS , Aug. 07, 2019 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2019 second quarter ended June 30, 2019 on Thursday, August 8,

Copyright West LLC. Minimum 15 minutes delayed.

RECENT FILINGS

Filing date Form
SC 13G
SC 13G
10-Q
8-K
Receive E-mail Alerts
 
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Investor Presentation
Investor Contacts
 
Martin Stammer
Chief Financial Officer
Stereotaxis, Inc.
investors@stereotaxis.com
© Copyright Stereotaxis 2019